21 CFR 209.11 - Dispensing and distributing the side effects statement.
prev | next
(a) Each authorized dispenser or pharmacy must distribute the side effects statement with each prescription drug product approved under section 505 of the act and dispensed. The side effects statement must be distributed with new and refill prescriptions.
(b) An authorized dispenser or pharmacy must choose one or more of the following options to distribute the side effects statement:
(1) Distribute the side effects statement on a sticker attached to the unit package, vial, or container of the drug product;
Title 21 published on 2014-04-01.
No entries appear in the Federal Register after this date, for 21 CFR Part 209.